ZIMMER, Robert H.; GUICHARD, Gilles; FREMAUX, Juliette; GOUDREAU, Sebastien; VENIN, Claire; MAURAN, Laura

Metadatos

Mostrar el registro completo del ítem

Licencia de uso del documento

ZIMMER, Robert H.

GUICHARD, Gilles

Chimie et Biologie des Membranes et des Nanoobjets [CBMN]

FREMAUX, Juliette

Idioma

Brevet

Este ítem está publicado en

2019

Resumen en inglés

The present description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the present disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the present disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.< Leer menos

URI

https://oskar-bordeaux.fr/handle/20.500.12278/4324

N° de patente

EP 3 466 979 A1

Centros de investigación

CBMN : Chimie & de Biologie des Membranes & des Nano-objets - UMR 5248